GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 733 filers reported holding GLAXOSMITHKLINE PLC in Q4 2014. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $33,029,000 | +17.8% | 762,100 | +10.2% | 0.03% | +17.2% |
| Q1 2016 | $28,048,000 | +101.4% | 691,700 | +100.4% | 0.03% | +93.3% |
| Q4 2015 | $13,928,000 | +2488.8% | 345,182 | +2368.8% | 0.02% | +1400.0% |
| Q3 2015 | $538,000 | -7.6% | 13,982 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $582,000 | -9.8% | 13,982 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $645,000 | +7.9% | 13,982 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $598,000 | -7.7% | 13,982 | -0.8% | 0.00% | 0.0% |
| Q3 2014 | $648,000 | -14.1% | 14,097 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $754,000 | -47.2% | 14,097 | -47.2% | 0.00% | 0.0% |
| Q1 2014 | $1,427,000 | +0.1% | 26,710 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,426,000 | -86.0% | 26,710 | -86.8% | 0.00% | -90.0% |
| Q3 2013 | $10,173,000 | +0.4% | 202,765 | -0.0% | 0.01% | -9.1% |
| Q2 2013 | $10,134,000 | – | 202,795 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |